These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27621198)

  • 21. Neuraminidase deficiency: case report and review of the phenotype.
    Young ID; Young EP; Mossman J; Fielder AR; Moore JR
    J Med Genet; 1987 May; 24(5):283-90. PubMed ID: 3585942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of severe action myoclonus in sialidoses.
    Canafoglia L; Franceschetti S; Uziel G; Ciano C; Scaioli V; Guerrini R; Visani E; Panzica F
    Epilepsy Res; 2011 Mar; 94(1-2):86-93. PubMed ID: 21330109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sialidosis Type I without a Cherry Red Spot- Is There a Genetic Basis?
    Neeraja K; Holla VV; Prasad S; Surisetti BK; Rakesh K; Kamble N; Yadav R; Pal PK
    J Mov Disord; 2021 Jan; 14(1):65-69. PubMed ID: 33121223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chaperone-mediated gene therapy with recombinant AAV-PPCA in a new mouse model of type I sialidosis.
    Bonten EJ; Yogalingam G; Hu H; Gomero E; van de Vlekkert D; d'Azzo A
    Biochim Biophys Acta; 2013 Oct; 1832(10):1784-92. PubMed ID: 23770387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pitfalls in Diagnosing Neuraminidase Deficiency: Psychosomatics and Normal Sialic Acid Excretion.
    Schene IF; Kalinina Ayuso V; de Sain-van der Velden M; van Gassen KL; Cuppen I; van Hasselt PM; Visser G
    JIMD Rep; 2016; 25():9-13. PubMed ID: 26141460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel spot mutation leading to sialidosis type 1-myoclonus syndrome and optical coherence tomography findings.
    Meşen S; Batur M; Ozer MD
    Arq Bras Oftalmol; 2023; 87(5):e20220069. PubMed ID: 39298726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurophysiolgical implications in sialidosis type 1: a case report.
    Wang F; Lin L; Hu J; Zhang J; Wang K
    Int J Neurosci; 2022 Jun; 132(6):589-592. PubMed ID: 32988250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Case of mucolipidosis type I with a primary alpha-D-neuraminidase deficiency].
    Louis JJ; Maire I; Hermier M; Nicolas A; Guibaud P
    J Genet Hum; 1983 Jun; 31(2):79-91. PubMed ID: 6415236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Pathogenic Variant in the
    Sahoo LK; Kota V; Panigrahi PK; Pattnaik S; Mishra AP; Sahoo SK;
    Neurology; 2023 Nov; 101(19):861-862. PubMed ID: 37604664
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnosis and Management of Type 1 Sialidosis: Clinical Insights from Long-Term Care of Four Unrelated Patients.
    Coppola A; Ianniciello M; Vanli-Yavuz EN; Rossi S; Simonelli F; Castellotti B; Esposito M; Tozza S; Troisi S; Bellofatto M; Ugga L; Striano S; D'Amico A; Baykan B; Striano P; Bilo L
    Brain Sci; 2020 Aug; 10(8):. PubMed ID: 32752208
    [No Abstract]   [Full Text] [Related]  

  • 31. Bergmeister's papilla in a young patient with type 1 sialidosis: case report.
    Rossi S; Gesualdo C; Tartaglione A; Bilo L; Coppola A; Simonelli F
    BMC Ophthalmol; 2020 Aug; 20(1):356. PubMed ID: 32867703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene therapy corrects the neurological deficits of mice with sialidosis.
    Hwu WL; Chang K; Liu YH; Wang HC; Lee NC; Chien YH
    Gene Ther; 2024 May; 31(5-6):263-272. PubMed ID: 38321198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fundus autofluorescence and optical coherence tomography of a macular cherry-red spot in a case report of sialidosis.
    Zou W; Wang X; Tian G
    BMC Ophthalmol; 2016 Mar; 16():30. PubMed ID: 27004518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mucolipidosis: clinical and genetic aspects].
    Kolodny EH
    Rev Neurol; 1998 Aug; 27(156):337-41. PubMed ID: 9736966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optical coherence tomography features in a case of Type I sialidosis.
    Wang IH; Lin TY; Kao ST
    Taiwan J Ophthalmol; 2017; 7(2):108-111. PubMed ID: 29018767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of human induced pluripotent stem cells (hIPSCs) from sialidosis types I and II patients with pathogenic neuraminidase 1 mutations.
    Han MJ; Annunziata I; Weesner J; Campos Y; Salie M; O'Reilly C; d'Azzo A
    Stem Cell Res; 2020 Jul; 46():101836. PubMed ID: 32485644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deficiency of neuraminidase in the sialidoses and the mucolipidoses.
    Den Tandt WR; Leroy JG
    Hum Genet; 1980; 53(3):383-8. PubMed ID: 7372342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elimination of abnormal sialylglycoproteins in fibroblasts with sialidosis and galactosialidosis by normal gene transfer and enzyme replacement.
    Oheda Y; Kotani M; Murata M; Sakuraba H; Kadota Y; Tatano Y; Kuwahara J; Itoh K
    Glycobiology; 2006 Apr; 16(4):271-80. PubMed ID: 16361247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Juvenile sialidosis: a rare case and review of the literature.
    Pokharel P; Dawadi A; Baral B; Dhungana S; Baskota A; Poudel DR
    Ann Med Surg (Lond); 2024 Apr; 86(4):2248-2252. PubMed ID: 38576973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuraminidase deficiency presenting as a nephrosialidosis: the first case detected in Poland.
    Tylki-Szymanska A; Lugowska A; Czartoryska B
    Acta Paediatr Jpn; 1996 Oct; 38(5):529-32. PubMed ID: 8942016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.